Development and validation of a two-stage convolutional neural network algorithm for segmentation of MRI white matter hyperintensities for longitudinal studies in CADASIL.

CADASIL MRI Neural network White matter hyperintensities automatic segmentation

Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
05 Aug 2024
Historique:
received: 06 01 2024
revised: 19 07 2024
accepted: 22 07 2024
medline: 7 8 2024
pubmed: 7 8 2024
entrez: 6 8 2024
Statut: aheadofprint

Résumé

Segmentation of white matter hyperintensities (WMH) in CADASIL, one of the most severe cerebral small vessel disease of genetic origin, is challenging. We adapted and validated an automatic method based on a convolutional neural network (CNN) algorithm and using a large dataset of 2D and/or 3D FLAIR and T1-weighted images acquired in 132 patients, to measure the progression of WMH in this condition. The volume of WMH measured using this method correlated strongly with reference data validated by experts. WMH segmentation was also clearly improved compared to the BIANCA segmentation method. Combining two successive learning models was found to be of particular interest, reducing the number of false-positive voxels and the extent of under-segmentation detected after a single-stage process. With the two-stage approach, WMH progression correlated with measures derived from the reference masks for lesions increasing with age, and with the variable WMH progression trajectories at individual level. We also confirmed the expected effect of the initial load of WMH and the influence of the type of MRI acquisition on measures of this progression. Altogether, our findings suggest that WMH progression in CADASIL can be measured automatically with adequate confidence by a CNN segmentation algorithm.

Sections du résumé

BACKGROUND BACKGROUND
Segmentation of white matter hyperintensities (WMH) in CADASIL, one of the most severe cerebral small vessel disease of genetic origin, is challenging.
METHOD METHODS
We adapted and validated an automatic method based on a convolutional neural network (CNN) algorithm and using a large dataset of 2D and/or 3D FLAIR and T1-weighted images acquired in 132 patients, to measure the progression of WMH in this condition.
RESULTS RESULTS
The volume of WMH measured using this method correlated strongly with reference data validated by experts. WMH segmentation was also clearly improved compared to the BIANCA segmentation method. Combining two successive learning models was found to be of particular interest, reducing the number of false-positive voxels and the extent of under-segmentation detected after a single-stage process. With the two-stage approach, WMH progression correlated with measures derived from the reference masks for lesions increasing with age, and with the variable WMH progression trajectories at individual level. We also confirmed the expected effect of the initial load of WMH and the influence of the type of MRI acquisition on measures of this progression.
CONCLUSION CONCLUSIONS
Altogether, our findings suggest that WMH progression in CADASIL can be measured automatically with adequate confidence by a CNN segmentation algorithm.

Identifiants

pubmed: 39106675
pii: S0010-4825(24)01021-7
doi: 10.1016/j.compbiomed.2024.108936
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108936

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Valentin Demeusy (V)

Medpace, Core Laboratory, 60-77 rue de la Villette, 69003, Lyon, France.

Florent Roche (F)

Medpace, Core Laboratory, 60-77 rue de la Villette, 69003, Lyon, France.

Fabrice Vincent (F)

Medpace, Core Laboratory, 60-77 rue de la Villette, 69003, Lyon, France.

May Taha (M)

Medpace, Biostatistics, 60-77 rue de la Villette, 69003, Lyon, France.

Ruiting Zhang (R)

Université Paris Cité, Inserm, NeuroDiderot, F-75019, Paris, France; Department of Radiology, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China.

Eric Jouvent (E)

Université Paris Cité, Inserm, NeuroDiderot, F-75019, Paris, France; Department of Neurology, Hôpital Lariboisiere, APHP, Paris, France; FHU NeuroVasc, Paris, France.

Hugues Chabriat (H)

Université Paris Cité, Inserm, NeuroDiderot, F-75019, Paris, France; Department of Neurology, Hôpital Lariboisiere, APHP, Paris, France; Centre de référence CERVCO - Centre Neurovasculaire Translationnel, Hôpital Lariboisiere, APHP, Paris, France; FHU NeuroVasc, Paris, France. Electronic address: hugues.chabriat@aphp.fr.

Jessica Lebenberg (J)

Université Paris Cité, Inserm, NeuroDiderot, F-75019, Paris, France; Centre de référence CERVCO - Centre Neurovasculaire Translationnel, Hôpital Lariboisiere, APHP, Paris, France; FHU NeuroVasc, Paris, France.

Classifications MeSH